Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells. – Brinkwire

Personalized cancer treatments are no longer just options of the future. In the past few years, researchers have made significant progress in ‘teaching’ the body’s immune T cells to recognize and kill specific cancer cells, and human clinical trials have shown that this approach can successfully eliminate tumors.
Cancer patients today can be a part of the following clinical scenario: A patient comes to the hospital where physicians and scientists analyze his or her tumor to identify cancer-spec…

Click here to view the original article.